XML 26 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock warrants
Common Stock
Common Stock
Pre-Funded Warrants
Common Stock
Common stock warrants
Additional Paid-In Capital
Additional Paid-In Capital
Common stock warrants
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024     47,714,708            
Beginning balance at Dec. 31, 2024 $ 79,626   $ 5     $ 461,339   $ 2 $ (381,720)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)     6,859            
Exercise of stock options and purchases pursuant to employee stock purchase plan 8         8      
Issuance of common stock upon settlement of restricted stock units (in shares)     232,076            
Taxes paid related to net share settlement of restricted stock units (in shares)     (54,403)            
Taxes paid related to net share settlement of restricted stock units (65)         (65)      
Stock-based compensation expense 1,721         1,721      
Unrealized gain (loss) on investments (2)             (2)  
Net Loss (13,702)               (13,702)
Ending balance (in shares) at Mar. 31, 2025     47,899,240            
Ending balance at Mar. 31, 2025 67,586   $ 5     463,003   0 (395,422)
Beginning balance (in shares) at Dec. 31, 2025     63,279,843            
Beginning balance at Dec. 31, 2025 82,390   $ 7     512,906   6 (430,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Proceeds from sale of common stock, net of offering costs (in shares)     5,000,000            
Proceeds from sale of common stock, net of offering costs 20,562         20,562      
Exercise of common stock warrants into common stock and pre-funded warrants (in shares)       6,928,891 153,664        
Exercise of common stock warrants into common stock and pre-funded warrants   $ 5,444         $ 5,444    
Exercise of stock options and purchases pursuant to employee stock purchase plan (in shares)     68,916            
Exercise of stock options and purchases pursuant to employee stock purchase plan 59         59      
Issuance of common stock upon settlement of restricted stock units (in shares)     206,513            
Taxes paid related to net share settlement of restricted stock units (in shares)     (56,040)            
Taxes paid related to net share settlement of restricted stock units (262)         (262)      
Stock-based compensation expense 2,415         2,415      
Unrealized gain (loss) on investments (6)             (6)  
Net Loss (14,767)               (14,767)
Ending balance (in shares) at Mar. 31, 2026     75,581,787            
Ending balance at Mar. 31, 2026 $ 95,835   $ 7     $ 541,124   $ 0 $ (445,296)